Maternal ethanol consumption: effects on G proteins and second messengers in brain regions of offspring.
Previous work in this and other laboratories has demonstrated that in utero ethanol exposure adversely affects the development of the serotonergic, dopaminergic, cholinergic, and other neurotransmitter systems. In several of these systems, receptor number is significantly altered. To determine whether the altered number of two G protein-linked receptors is reflected in changes in cell function, we examined dopamine-stimulated adenylate cyclase in the striatum and cortex and carbachol-stimulated phosphoinositide (PI) hydrolysis in the cortex. Serotonin-stimulated cortical PI hydrolysis was assessed for comparison. We also studied G proteins that link adenylate cyclase and other second messenger systems to their receptors. The G proteins that were analyzed include the alpha-subunits for Gs, G0, Gi1, Gi2, and Gi3. G proteins were analyzed in the cortex and cortical regions, as well as in the brain stem. The results of these experiments demonstrated that dopamine-stimulated adenylate cyclase activity was comparable in the striatum of 5- and 19-day offspring of control and ethanol-fed rats and in the motor cortex of 19-day offspring. We also found that carbachol- and serotonin-stimulated hydrolysis of cortical phosphoinositides was unchanged in ethanol-exposed offspring on gestational day 19, and on postnatal days 5 and 19. G protein content was examined by Western blot analysis, using antibodies directed against the alpha-subunits of Gs, G0, and the Gi1/Gi2 and Gi3/G0 combinations. These investigations indicated that, with two minor exceptions (approximately 10% change in the proteins detected by antibodies against the alpha-subunits of the Gi1/Gi2 and Gi3/G0 combinations), there were no significant differences in the content of any of the G proteins analyzed.
Druse
M J
MJ
Department of Molecular and Cellular Biochemistry, Loyola University of Chicago, Stritch School of Medicine, Maywood, Illinois.
Tajuddin
N F
NF
Eshed
M
M
Gillespie
R
R
D000109:Acetylcholine / Q000502:physiology; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D001933:Brain Stem / Q000187:drug effects / Q000503:physiopathology; D015220:Calcium Channels / Q000187:drug effects / Q000502:physiology; D002540:Cerebral Cortex / Q000187:drug effects / Q000503:physiopathology; D004298:Dopamine / Q000502:physiology; D005260:Female; D063647:Fetal Alcohol Spectrum Disorders / Q000503:physiopathology*; D019204:GTP-Binding Proteins / Q000145:classification / Q000502:physiology*; D006868:Hydrolysis / Q000187:drug effects; D008297:Male; D010716:Phosphatidylinositols / Q000378:metabolism; D015221:Potassium Channels / Q000187:drug effects / Q000502:physiology; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D015290:Second Messenger Systems / Q000187:drug effects* / Q000502:physiology; D012701:Serotonin / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects* / Q000502:physiology
D015220:Calcium Channels; D010716:Phosphatidylinositols; D015221:Potassium Channels; D012701:Serotonin; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases; D000109:Acetylcholine; D004298:Dopamine